Notice of Registration - 2012
[Federal Register Volume 77, Number 202 (Thursday, October 18, 2012)]
[Notices]
[Page 64143]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25634]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Cambridge Isotope Lab
By Notice dated June 18, 2012, and published in the Federal
Register on June 26, 2012, 77 FR 38086, Cambridge Isotope Lab, 50
Frontage Road, Andover, Massachusetts 01810, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of Morphine (9300), a basic class of controlled
substance listed in schedule II.
The company plans to utilize small quantities of the listed
controlled substance in the preparation of analytical standards.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cambridge Isotope Lab to manufacture the listed basic class of
controlled substance is consistent with the public interest at this
time. DEA has investigated Cambridge Isotope Lab to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic class of controlled substance listed.
Dated: October 9, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-25634 Filed 10-17-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
